Katharine Cuff

Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies

Hui Yi Chew, Priscila Oliveira de Lima, Jazmina L. Gonzalez Cruz et al. · Cell · 2020 · 179 citations

Autoimmune Disease, Autoantibody Production, Endocytosis Inhibition +12

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · The Lancet Oncology · 2023 · 175 citations

Urology, Oncology, Genitourinary Cancer +7

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

Shankar Siva, Mathias Bressel, Simon Wood et al. · European Urology · 2021 · 132 citations

Short-course Pembrolizumab, Urology, Surgical Oncology +7

SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer

Joshua T. Burgess, Emma Bolderson, Jodi M. Saunus et al. · Oncotarget · 2016 · 32 citations · Full text

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

Frede Donskov, Robert J. Motzer, Éric Voog et al. · European Journal of Cancer · 2019 · 26 citations · Full text